Related Experiment Videos
Platelet talin is phosphorylated by calyculin A
K Murata1, M Sakon, J Kambayashi
1Department of Surgery II, Osaka University Medical School, Japan.
Journal of Cellular Biochemistry
|January 1, 1995
Summary
Protein phosphatase inhibitors calyculin A and okadaic acid block platelet aggregation. Talin phosphorylation by these inhibitors correlates with reduced platelet function, suggesting phosphatases regulate cell interactions.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Protein phosphatases, specifically types 1 and 2A, are crucial regulators of cellular processes.
- Inhibitors like calyculin A and okadaic acid affect platelet aggregation and secretion, but the underlying mechanisms are unclear.
- Talin is a key protein in the cytoskeleton, linking membrane proteins to actin filaments.
Purpose of the Study:
- To investigate the relationship between protein phosphatase inhibition and platelet function.
- To determine the role of talin phosphorylation in the observed effects of phosphatase inhibitors on platelets.
Main Methods:
- Treatment of unstimulated platelets with calyculin A.
- Analysis of talin phosphorylation at threonine residues.
- Correlation of talin phosphorylation levels with thrombin-induced platelet aggregation inhibition.
Main Results:
- Calyculin A induced threonine phosphorylation of talin (P235) in unstimulated platelets.
- The degree of talin phosphorylation directly correlated with the inhibition of platelet aggregation.
- Phosphorylation of talin affects its binding to the platelet glycoprotein IIb/IIIa complex.
Conclusions:
- Type 1 and/or type 2A protein phosphatases are implicated in regulating platelet membrane-cytoskeleton interactions.
- Dephosphorylation of talin by these phosphatases is a potential mechanism for controlling platelet function.